3Suppliers
2Customers
3Debt Items
20Related Chains

PepGen Inc. Suppliers

TickerNameConfidenceEvidence
MEDICAL-RESEARCH-COUNCIL MEDICAL-RESEARCH-COUNCIL 90% Pursuant to the OUI/MRC License, we obtained from OUI and MRC an exclusive, royalty-bearing, sublicensable with consent (through one tier) license under certain patent rights, or the OUI/MRC Patents,…
MEDICAL-RESEARCH-COUNCIL-OF-UNITED-KINGDOM-RESEA MEDICAL-RESEARCH-COUNCIL-OF-UNITED-KINGDOM-RESEA 90% The License Agreement provides the Company with an exclusive world wide license to licensed data and technology owned by OUI and MRC in respect of cell-penetrating peptides for the treatment of Duche…
OUI OUI 90% The License Agreement provides the Company with an exclusive world wide license to licensed data and technology owned by OUI and MRC in respect of cell-penetrating peptides for the treatment of Duche…

PepGen Inc. Customers

TickerNameConfidenceEvidence
RA-CAPITAL-MANAGEMENT-L-P RA-CAPITAL-MANAGEMENT-L-P 80% Entities affiliated with RA Capital Management, L.P., or RA Capital, purchased common stock in the Company's IPO in May 2022, the Company's 2024 Offering in February 2024, and the Company's 2025 Offe…
OXFORD-SCIENCE-ENTERPRISES OXFORD-SCIENCE-ENTERPRISES 70% Oxford Science Enterprises, or OSE, which is an affiliate of OUI, owned 7.2 % of the Company's outstanding common stock as of March 31, 2026.

PepGen Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PEPG-DEBT-11733 Xbrl Convertible 90% xbrl convertible detail from xbrl 2022-12-31.
PEPG-DEBT-11732 Warrants outstanding: 406000 90% xbrl warrant detail from xbrl 2022-12-31.
PEPG-DEBT Debt stack $16.6M 90% Market cache reports total debt of $16.6M.

PepGen Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for PepGen Inc..

PepGen Inc. Ownership

HolderNameConfidenceEvidence
PEPG-OWNER-RA-CAPITAL-MANAGEMENT-L-P RA CAPITAL MANAGEMENT, L.P. 90% 13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 95 tracked holders.

PepGen Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CABA Cabaletta Bio, Inc. 100.00 2
BMRN BioMarin Pharmaceutical Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CPRX Catalyst Pharmaceuticals, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 1 ['receiving']
PSNL Personalis, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
BCYC Bicycle Therapeutics plc 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
BNTC Benitec Biopharma Inc. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
NVO Novo Nordisk A/S 100.00 2
RGNX REGENXBIO Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
TECX Tectonic Therapeutic, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 1 ['receiving']
ELVN Enliven Therapeutics, Inc. 100.00 2